|
Post by mnkdorbust on Nov 19, 2015 20:54:49 GMT -5
On what could be a related note, The MNKD short volume ratio hit an all-time low of 7.5% today. Coincidence that Lakers said BOD were meeting today? Perhaps tomorrow will add more clarity in some way. Shorts were probably tied up with the KaloBios mess today.
|
|
|
Post by jeremg on Nov 19, 2015 20:57:02 GMT -5
On what could be a related note, The MNKD short volume ratio hit an all-time low of 7.5% today. Coincidence that Lakers said BOD were meeting today? Perhaps tomorrow will add more clarity in some way. That is just an alien number to this stock, I'm hoping this means something of significance. If they stopped further shorting the stock I would expect to see a smooth unravelling of the short position and a steady orderly increase in PPS (3.5% per day?) as we saw today.
|
|
|
Post by rockstarrick on Nov 19, 2015 21:12:26 GMT -5
BoD is still in session as of Thursday today 11/19/15. Pain/Migraine partnership is being discussed as one of topics. Pain med passed animal trial, was ready for human clinical trial. It's furthest along among APIs. Please do your own DD before passing judgement.You can partially verify some. Do not lock this thread just because you can't verify on your own for the benefit of others, out of respect for the long-suffering Old Faithfuls such as rock, kball, dbc, mnholdem, kc, spiro, rob, resident PCPs, ... Thank you lakers
|
|
|
Post by rockstarrick on Nov 19, 2015 21:19:49 GMT -5
BoD is still in session as of Thursday today 11/19/15. Pain/Migraine partnership is being discussed as one of topics. Pain med passed animal trial, was ready for human clinical trial. It's furthest along among APIs. Please do your own DD before passing judgement.You can partially verify some. Do not lock this thread just because you can't verify on your own for the benefit of others, out of respect for the long-suffering Old Faithfuls such as rock, kball, dbc, mnholdem, kc, spiro, rob, resident PCPs, ... Passed animal trials?? Don't ya wonder how they know when a mouse has a headache and when it's gone ?? Sounds like a post for YMB . Wow, what a statement, you do know most if not all new drugs are first tested on animals right ?? Even our Afrezza started out with animal trials. This is easily verified if you know where to look. Do your own DD
|
|
|
Post by rockstarrick on Nov 19, 2015 21:22:12 GMT -5
Just a guess, but I would imagine that animal trials are used to prove safety rather than efficacy. In other words, prove that it doesn't kill an animal before you give it to a human. Can it be overdosed ? how much ? non-opioid, is it addictive? Built-up resistance... I repeat do not pass judgment until after your thorough DD. Keep up the great work lakers.
|
|
|
Post by rockstarrick on Nov 19, 2015 21:26:01 GMT -5
If there is any remote chance that the "insulin human" being reviewed by EMA is Afrezza, they are supposed to have a "CHMP opinion" today and we will probably know the result by tomorrow. If it is not Afrezza, we will also know. I thought I read on the EMA site that the transcripts would be available 11/25/2015
|
|
|
Post by rockstarrick on Nov 19, 2015 21:27:45 GMT -5
Time for a thumbs down button on some of these posters. Go Lakers! Agree 100%
|
|
|
Post by suebeeee1 on Nov 19, 2015 21:32:52 GMT -5
Time for a thumbs down button on some of these posters. Go Lakers! Agree 100% Agreed 1000%! I have wished many, many times that we had a thumbs down button. Can the admins add one?
|
|
|
Post by liane on Nov 20, 2015 5:17:35 GMT -5
Sorry - thumbs down button is not an option.
|
|
|
Post by vestful on Nov 20, 2015 7:17:02 GMT -5
Sorry - thumbs down button is not an option. Thumbs down;) c'mon ProBoards...
|
|
|
Post by kimi on Nov 20, 2015 7:20:16 GMT -5
The CHMP adopted a negative opinion for Solumarv (insulin human) which was expected to be used to treat patients with diabetes who require insulin to control their blood sugar levels. Solumarv was developed as a biosimilar medicine. For more information, please see the questions-and-answers document in the grid below.
|
|
|
Post by benyiju on Nov 20, 2015 9:49:59 GMT -5
|
|
|
Post by benyiju on Nov 20, 2015 10:23:27 GMT -5
|
|
|
Post by mnholdem on Nov 20, 2015 11:14:09 GMT -5
This application (case file #002506) is not the same case file as was previously being discussed. If you read the information on the link provided (above) you'll find the following:
On 15 November 2012, Marvel LifeSciences Ltd officially notified the Committee for Medicinal Products for Human Use (CHMP) that it wishes to withdraw its application for a marketing authorisation for Solumarv, intended for the treatment of patients with diabetes who require insulin to control their blood glucose.
Sorry... but this is not the mystery insulin we're wanting to find out about.
|
|
|
Post by dreamboatcruise on Nov 20, 2015 12:55:42 GMT -5
Please do not lock this thread which is created b/c the following thread was locked. 3Q15 ER Mon 11/9/15; BoD to convene Nov 2nd half to decide created Oct 29, 2015 at 1:43pm mnkd.proboards.com/thread/3875/3q15-mon-convene-half-decide?page=5Hakan 3Q15 CC 11/9/15: Negotiating with many for TS partnership- Will have partner by end of year The 50M Mnkd Shares TASE index funds got is such a sweet deal. Al'd rather offer to them than Sny. He really plays hard ball w/ Sny who must be really stingy. lakers... so is the result of the BOD meeting what you expected or a surprise? Might a TS partnership deal falling through been the proximate cause of a change of leadership?
|
|